1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Tocilizumab
Trade Name:
Actemra
Manufacturer/Distributor:
Hoffman-La Roche
www.rochecanada.com
Classification:
Interleukin-6 inhibitor
ATC Class:
L04AC07 - Tocilizumab
Status:
active
Notice of Compliance (yyyy/mm/dd):
2010/04/30
Date Marketed in Canada (yyyy/mm/dd):
2010/05/26
Presentation:
Injection: 80 mg/4 mL. DIN:02350092
Injection: 200 mg/10 mL. DIN: 02350106
Injection: 400 mg/20 mL. DIN: 02350114
Comments:
For treatment of moderate to severe active rheumatoid arthritis who have had inadequate response to DMARDs and/or TNF antagonists.
Back to:
Drug Product Listings 
